Clinical Research Directory
Browse clinical research sites, groups, and studies.
Perennial Malaria Chemoprevention (PMC) Effect Study
Sponsor: Malaria Consortium
Summary
The Malaria Consortium Nigeria (MC) will coordinate a trial of PMC in Osun State, Nigeria with strategic support from the National Malaria Elimination Programme of the Government of Nigeria (NMEP) and financial support from the BMGF. The primary purpose of the study is to provide evidence of the impact of PMC on malaria burden and related clinical outcomes, and its operational feasibility for policy decision and the inclusion of PMC into upcoming programme and funding cycles for its National Malaria Control Strategic Plan. The objectives are: 1. To evaluate the impact of PMC in children aged 2-18 months on key child health outcomes including malaria burden, hospitalisations, and anaemia. 2. To describe indicators of operational feasibility of PMC by identification and measurement of key determinants of successful uptake and implementation of PMC.
Official title: Perennial Malaria Chemoprevention (PMC) Effect Study: Nigeria Operational Feasibility and Effectiveness
Key Details
Gender
All
Age Range
10 Weeks - 24 Months
Study Type
INTERVENTIONAL
Enrollment
2000
Start Date
2023-08-08
Completion Date
2026-12
Last Updated
2023-12-04
Healthy Volunteers
Yes
Conditions
Interventions
Perennial Malaria Chemoprevention effect
Assessing the effectiveness and feasibility of Perennial malaria chemoprevention delivery through EPI platform.
Locations (1)
Ministry of Health
Oshogbo, Osun State, Nigeria